Africa Oil Corp (TSX:AOI) has earned a repeat ‘Buy’ rating from analysts at Stifel following the release of its fourth quarter financial and performance results.
The analysts highlighted that Africa Oil’s results were within guidance and slightly ahead of their estimates, with the consolidation of Prime imminent.
Dell Technologies Inc (NASDAQ:DELL) shares fell in early trade on Friday after the computer hardware and software firm reported mixed results for the fourth quarter and guidance below expectations.
Q4 earnings of $1.91 billion or $2.68 per share were ahead of Wall Street estimates of $2.52 but revenue of $23.9 billion missed the consensus $24.6 billion.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) can reward shareholders with dividends and share buybacks, and drive its market valuation significantly higher - that’s the view of analysts at Berenberg.
The European Bank rates Endeavour as a ‘buy’ with a 2,100p price target, versus the market price of just over 1,500p.
SP Angel expects a strong production rebound in 2025 from Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) after last year’s operational disruptions. The boutique mining house expects record revenues as gold and copper output surges.
The company forecasts 2025 production of 28-33koz of gold (up from 15.1koz in 2024) and 6.5-6.8kt of copper (from just 0.4kt). Revenues are expected at $110-125m, with EBITDA between $45-55m.
Salesforce Inc (NYSE:CRM, ETR:FOO) shares moved lower after the customer relationship management (CRM) software provider reported a revenue miss for the fourth quarter and issued conservative guidance.
For Q4, revenue of $9.99 billion marked an 8% year-over-year increase by missed estimates of $10.04 due to a $75 million FX headwind.
Abacus Life Inc (NASDAQ:ABL) is gaining traction among analysts as it transitions from a life settlements firm into a broader asset management player.
Analysts at Autonomous Research, Northland, and Piper Sandler see the alternative asset management company as significantly undervalued, with a strong market position, growing revenue streams, and potential for valuation upside.
Haleon PLC's (LSE:HLN, NYSE:HLN) prelims have reassured investors, with earnings per share (EPS) beating expectations by 6% in the second half of 2024, according to analysts - although the shares succumbed to a bout of profit taking in their wake.
The consumer health giant reported 5% organic growth for the year, slightly ahead of market forecasts, Stifel said.
BP PLC's (LSE:BP.) strategy update to investment more in oil & gas and less in renewables was largely in line with expectations for investment banking analysts, but they warned the company faces "execution risks" as it needs to hit the top end of targets to really impress markets.
Citi noted that given the “voluminous press coverage of recent weeks, BP’s strategy update (reset) was never likely to surprise.”
Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.2% in early trading as investors saw little in the results to justify further gains at current valuations.
While full-year sales and profits met expectations, analysts noted a lack of clear catalysts.
Nvidia Corp (NASDAQ:NVDA, ETR:NVD) shares fell in pre-market trading as investors weighed strong fourth-quarter earnings against signs of slowing growth.
The chipmaker posted revenue of $39.33 billion, ahead of analyst forecasts, with adjusted earnings per share of $0.89 also beating expectations.
Nvidia Corp (NASDAQ:NVDA, ETR:NVD) is set to report fourth-quarter earnings this afternoon, with analysts weighing potential outcomes ahead of the company's highly anticipated GPU Technology Conference (GTC) in March.
Bank of America analysts see Nvidia benefiting from strong AI hardware demand.
Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) has taken another step towards enhancing the economics of its Angel Island lithium project, a move welcomed by analysts at Noble Capital Markets.
The initial internal optimization study identified cost reductions of up to 25% or $395.2 million from Phase 1 capital expenditures which total $1.58 billion.
JP Morgan is optimistic about Novo Nordisk (NYSE:NVO) despite competition from Eli Lilly’s new drug, orforglipron.
Its analysts reckon Novo will hold its ground if Lilly’s upcoming trial results match Novo’s existing treatments.
UBS is playing the long game on Manchester United Plc (NYSE:MANU), despite the club being on track for its worst-ever Premier League finish.
The bank has cut its earnings estimates for 2025 and 2026, reflecting a predicted 15th-place finish this season and a mid-table recovery to 10th next year.
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell 5% in early trading as investors took profits despite the company reporting strong results and an upbeat outlook for 2025.
Revenue for 2024 rose 9% to $3.13 billion (£2.47 billion), while operating profit surged 67% to $612 million (£483 million).
AMC Entertainment Holdings (NYSE:AMC) is facing tough revenue comparisons for the fourth quarter of 2024 after distributing the Taylor Swift and Beyonce concert films in Q4 2023.
Analysts at Wedbush expect AMC to report Q4 revenue of $1.274 billion, up 15% year-over-year but below the Wall Street consensus of $1.298 billion.
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF) is expected to continue growing its output in the United States, thanks to its initial successes with the drill bit.
David Mirzai, analyst at City broker SP Angel, who rates Union Jack as a ‘buy’ with a 66p target, anticipates cash thrown off from these first wells in Oklahoma will be reinvested into other ‘low-risk near-term US drilling opportunities’.
Kosmos Energy Ltd's (LSE:KOS, NYSE:KOS) performance last year was below expectations, but "there are signs of progress and some growth should be anticipated" for 2025, broker Panmure Liberum said.
Analyst Ashley Kelty, affirming his 'buy' rating but cutting his target price to 535p from 625p, summed up the year as one of "faltering progress".
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) is gaining momentum. The company, known for its oral iron supplement ACCRUFeR, has reported a strong end to 2024, with US sales driving record revenues for the year of $32.2 million, according to a research note from Cavendish.
That’s a 153% increase from the previous year, putting Shield on track to break even by late 2025.
When Haleon PLC (LSE:HLN, NYSE:HLN) reports results on Thursday, 27 February, Barclays expects its sales of painkillers to have offset the "well known headwind" from a weak start to the cold and flu season in the final quarter of 2024.
Analysts at the bank said that earnings delivery and profit margin expansion are the main areas of focus for investors in the FTSE 100 consumer health products group too, while Futura Medical investors are likely to be keeping an eye out for news on the Eroxon collaboration.
Nike Inc (NYSE:NKE, ETR:NKE) shares moved higher after Jefferies analysts upgraded the company to a ‘Buy’ rating and boosted their price target to $115.
The analysts previously had a ‘Hold’ rating and a $75 price target on the athletic apparel and footwear brand.
Rivian Automotive Inc (NASDAQ:RIVN) shares slumped more than 7% after the electric vehicle maker was downgraded by Bank of America analysts.
They downgraded Rivian to “Underperform” from “Neutral” and awarded it a $10 price target, down from $13. Shares traded down 7.5% at $12 late morning on Monday.
Tesla Inc (NASDAQ:TSLA) is gearing up for a pivotal few months, with new vehicle launches, advancements in autonomous driving, and CEO Elon Musk’s growing involvement in external ventures stirring debate.
The electric vehicle maker’s stock has had a bumpy start to 2025, following a post-election surge in November. Now, as Tesla prepares to roll out key initiatives, investors are weighing the potential upside against concerns about Musk’s focus.
Tim Cook continues to prove that he is 10% politician and 90% CEO
Apple Inc (NASDAQ:AAPL, ETR:APC) is making a massive $500 billion bet on the US economy, and it could not have come at a more interesting time.
Supermarket Income REIT PLC (LSE:SUPR, OTC:SUPIF) shares offer value and a dividend yield of 8.6%, said broker Stifel as it reiterated its 'buy' recommendation at 80p share price target.
This followed an update from the real estate investment trust about various recent portfolio initiatives, including the sale of one Tesco store, lease renewals on three other Tesco sites and the acquisition of a handful more Carrefour supermarkets in France.
Melrose Industries PLC (LSE:MRO, OTC:MLSPF) shares recievd a boost after RBC Capital raised its price target for the aerospace-focused manufacturer to 760p from 650p, citing an improving cash flow outlook and strong growth potential.
The bank maintained its 'outperform' rating, suggesting there is further room for the stock to rise.